Spectrum Pharmaceuticals Inc
SPPI
SPPI was delisted on the 31st of July, 2023.
169 hedge funds and large institutions have $282M invested in Spectrum Pharmaceuticals Inc in 2019 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 52 increasing their positions, 51 reducing their positions, and 21 closing their positions.
38% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 21
1% more funds holding
Funds holding: 167 → 169 (+2)
2% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 51
8% less call options, than puts
Call options by funds: $5.65M | Put options by funds: $6.12M
60% less capital invested
Capital invested by funds: $708M → $282M (-$426M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$9.99M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.2M |
| 3 |
BlackRock
New York
|
+$5.07M |
| 4 |
Morgan Stanley
New York
|
+$4.02M |
| 5 |
State Street
Boston,
Massachusetts
|
+$4.02M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Primecap Management
Pasadena,
California
|
-$36.8M |
| 2 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$28.9M |
| 3 |
VOYA Investment Management
Atlanta,
Georgia
|
-$7.64M |
| 4 |
SIM
Sonora Investment Management
Tucson,
Arizona
|
-$5.72M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.46M |
SPPI Hedge Fund Activity: Q4 2019 in Review
169 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q4 2019, worth a combined $282M — down 60% from $708M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new SPPI positions and 21 closed out — a net gain of 8 holders — while 52 added to existing stakes and 51 trimmed.
The largest buyer was Wellington Management Group, opening a new position worth an estimated $9.99M. The largest seller was Primecap Management, cutting an estimated $36.8M.
- 169 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q4 2019, up from 167 in Q3 2019.
- Funds reported $282M of Spectrum Pharmaceuticals Inc stock for Q4 2019, down 60% quarter-over-quarter.
- 29 funds opened new Spectrum Pharmaceuticals Inc positions in Q4 2019 and 21 closed out, a net change of +8 holders.
- The largest Spectrum Pharmaceuticals Inc buyer in Q4 2019 was Wellington Management Group, an estimated $9.99M added.
- The largest Spectrum Pharmaceuticals Inc seller in Q4 2019 was Primecap Management, an estimated $36.8M sold.
Based on aggregated 13F filings for Q4 2019.